Clients

Emerald Health Therapeutics

Company Snapshot: Emerald Health Therapeutics

EMHTF
Last Change Volume High Low

Company Overview

Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD) is a Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes. Emerald owns 50% of Pure Sunfarms, which is converting a licensed existing 1.1 million square foot greenhouse in Delta, BC, and is in commercial production. It owns Agro-Biotech, a Québec-based licensed cannabis grower with a 75,000 square foot indoor facility and is planning to add a 500,000 square foot greenhouse in Metro Vancouver. Emerald’s team is highly experienced in life sciences, product development, large-scale agri-business, and marketing, and is focused on developing value- added cannabis-based products with potential wellness and medical benefits. Emerald is part of the Emerald Health group, which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.

Client News

  1. Jun 14 2019 Emerald Health Therapeutics Applauds the Government of Canada for the Release of Final Ingestible Regulations
  2. Jun 13 2019 Emerald Health Therapeutics to Present At Oppenheimer Consumer Growth and E-Commerce Conference
  3. Jun 12 2019 Emerald Health Therapeutics Contracts for 1,200 Acres of Canadian Hemp Harvest, Reports Significant Progress on Factors Group Extraction Facility, and Forms US Hemp Subsidiary
  4. Jun 3 2019 Emerald Health Therapeutics to Participate at Investment and Industry Conferences in June